卓悅控股(00653)遭執董入稟追還4,430萬元
卓悅控股(00653.HK)公布,間接全資附屬卓悅化粧品批發中心收到執行董事鍾佩雲作為第一原告及宇東科技作為第二原告之代表律師於香港高等法院原訟法庭所出具關於針對被告的案件之傳訊令狀。
如傳訊令狀所述,原告向被告申索歸還根據於2018年9月至2020年6月期間原告向被告所預先提供且應按要求或於具有及收到款項後立即償還的一系列貸款應收被告未償還款項總額4,430萬元。原告申索歸還總額4,430萬元,或返還性損害賠償金、利息及成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.